NIH awards SBIR grant to AVM for lymphoma drug research
The National Institutes of Health grant to AVM Biotechnology will be used to evaluate a drug to treat non-Hodgkin’s lymphoma combined with standard of care.
Archives for August 25, 2022
BMS forges multi-year research partnership with PathAI
The pharmaceutical company and the artificial intelligence pathology specialist will focus on translational research in oncology, fibrosis, and immunology.